Form 4: Klaviyo Exec Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Klaviyo Co-Chief Executive Andrew Bialecki reported the sale of 200,000 shares of Series A Common Stock for $18.63 per share, executed under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Andrew Bialecki, Co-Chief Executive Officer, Director, and 10% Owner of Klaviyo, Inc., reported a transaction on April 7, 2026.
- The transaction involved the disposition of 200,000 shares of Series A Common Stock.
- These shares were sold at a weighted average price of $18.63 per share, with individual sales ranging from $18.31 to $18.94.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on May 20, 2025, which is designed to satisfy affirmative defense conditions for insider trading.
- Following the transaction, Bialecki beneficially owns a significant number of securities, including Series A and Series B Common Stock held directly and indirectly through various trusts.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the significant sale by a top executive, even though it was executed under a pre-planned 10b5-1 trading plan.
Negatives
- A significant number of shares (200,000) were sold by a key executive, which could be perceived negatively by the market, despite being executed under a pre-planned trading strategy.
Risks
- The Rule 10b5-1 plan is intended to provide an affirmative defense against allegations of insider trading, but the execution of such a plan can still lead to market perception concerns.
- The weighted average sale price of $18.63 per share, with a range of $18.31 to $18.94, indicates a disposition of equity at a specific market valuation.
Future Outlook
The filing does not contain forward-looking statements or guidance. It solely reports on a past transaction.
Industry Context
StockSavvy.ai notes that insider sales, even under Rule 10b5-1 plans, are closely watched by investors. Such transactions can sometimes signal a lack of confidence in future stock performance or a desire for personal liquidity, although the pre-planned nature of a 10b5-1 trade aims to mitigate these concerns.
Stakeholder Impact
- Shareholders may interpret the sale as a signal of reduced confidence by a key executive, potentially impacting short-term stock sentiment.
- The execution of the sale under a Rule 10b5-1 plan is intended to mitigate concerns about insider trading, providing some reassurance to investors.
- Creditors and suppliers are unlikely to be directly impacted by this specific transaction.
Next Steps
- The reporting person will continue to adhere to the terms of the Rule 10b5-1 trading plan.
- Further transactions may be reported on subsequent Form 4 filings if they occur under the plan or through other means.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 04/07/2026 | Date of the reported transaction (sale of Series A Common Stock). |
| 04/09/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe sale was executed under a pre-established Rule 10b5-1 plan, indicating it was planned in advance and not based on recent material non-public information. While a large sale by an executive can be a negative signal, the planned nature of the transaction suggests it's more about personal liquidity or diversification rather than a bearish outlook on the company's future. Therefore, a 'hold' recommendation is appropriate, pending further fundamental analysis of Klaviyo's business performance.
Keywords
Klaviyo, KVYO, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Beneficial Ownership, Securities Transaction, Andrew Bialecki, Series A Common Stock, Series B Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.